EU POLICY ON ORPHAN DRUGS

被引：1
|
作者：
LEWIS, S
机构：
来源：
LANCET | 1995年 / 345卷 / 8963期
关键词：
D O I：
10.1016/S0140-6736(95)91053-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1500 / 1500
页数：1
相关论文
共 50 条
  • [41] PRICE DIFFERENCES FOR ORPHAN DRUGS ACROSS THE EU-5 COUNTRIES: A COMPARATIVE ASSESSMENT
    Brosa, M.
    Prada, M.
    Berard, I
    Vollmer, L. M.
    Guterres, S.
    VALUE IN HEALTH, 2018, 21 : S464 - S464
  • [42] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
    Shiragami, M
    Nakai, K
    DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
  • [43] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
    Ounsirithupsakul, T.
    Samphansompoch, T.
    Sermsakulthai, T.
    Taychakhoonavudh, S.
    VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [44] Dutch doctors call for EU evaluation of cost effectiveness of high cost orphan drugs
    Sheldon, Tony
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [45] Safety-Related Regulatory Actions for Orphan Drugs in the US and EU A Cohort Study
    Heemstra, Harald E.
    Giezen, Thijs J.
    Mantel-Teeuwisse, Aukje K.
    de Vrueh, Remco L. A.
    Leufkens, Hubert G. M.
    DRUG SAFETY, 2010, 33 (02) : 127 - 137
  • [46] EU creates united policy to fight fake drugs
    Rogers, A
    CHEMISTRY WORLD, 2004, 1 (05): : 10 - 10
  • [47] ORPHAN DISEASES AND ORPHAN DRUGS - SCHEINBERG, WALSHE
    QURESHI, B
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1987, 107 (04): : 160 - 160
  • [48] Orphan drugs for myelofibrosis
    Harrison, Claire N.
    Bennett, Michael
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 391 - 405
  • [49] The problem of orphan drugs
    Ferner, Robin E.
    Hughes, Dyfrig A.
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [50] Orphan drugs in Europe
    Emma Dorey
    Nature Biotechnology, 1999, 17 (8) : 737 - 737
12345